What Are The Primary Absolute And Relative Contraindications Practitioners Must Screen For Prior To Operating Fractional Laser Devices? Essential Screening Guide For Safe Treatment

Before operating a fractional laser, practitioners must first exclude active infection and recent oral isotretinoin use. The primary absolute contraindications are an active localized bacterial, viral, or fungal infection in the treatment area and current or recent isotretinoin—or a related systemic retinoid—use within the preceding 6 months. Relative contraindications include photosensitivity, pregnancy or breastfeeding, and unrealistic expectations; these require individualized risk assessment, modification, postponement, or physician consultation.

Screening must distinguish conditions that require exclusion from those requiring caution. The exact retinoid-free interval and other restrictions may vary by device, treatment depth, and institutional protocol, so practitioners should follow the manufacturer’s instructions and applicable clinical guidance.

Absolute Contraindications That Require Deferral

Active Localized Infection

Do not treat skin with an active bacterial, viral, or fungal infection. Fractional laser treatment can further disrupt the epidermal barrier and may worsen infection, delay healing, or increase the risk of spreading infection.

Treatment should be postponed until the infection and any associated inflammation have resolved. A history of herpes simplex is not automatically an absolute contraindication, but it requires specific assessment and, where appropriate, antiviral prophylaxis.

Recent or Current Oral Isotretinoin Use

Current use of isotretinoin or related oral retinoids is an absolute contraindication under the primary screening standard. Treatment should also be deferred when the medication was used within the previous 6 months.

Retinoid washout periods are not universal. Some protocols recommend longer intervals—such as 6 to 12 months—particularly for aggressive ablative resurfacing, so the practitioner must verify the specific device protocol and prescriber guidance rather than applying one interval to every laser treatment.

Relative Contraindications Requiring Individual Assessment

Photosensitivity

Photosensitivity caused by collagen vascular disease or light-sensitizing medications increases the risk of excessive inflammation, burns, pigmentary changes, or delayed healing.

The clinician should review medical history and medications, assess the patient’s current photosensitivity risk, and determine whether treatment should be postponed, modified, or avoided. Relevant medication changes should be managed by the prescribing clinician rather than made independently by the laser operator.

Pregnancy and Breastfeeding

Pregnancy and breastfeeding should be treated as relative contraindications requiring a careful risk-to-benefit discussion. The primary reference calls for physician consultation, particularly with the patient’s obstetric or other appropriate medical provider.

In the absence of a compelling clinical reason and adequate medical agreement, elective fractional laser treatment is generally best postponed. The decision should account for the treatment area, laser type, anesthetic or topical products, and the limited need for elective exposure during this period.

Unrealistic Expectations

Unrealistic expectations are a clinical contraindication to proceeding safely, even when the patient has no medical risk factors. Fractional lasers can improve selected concerns, but results depend on the indication, device, treatment parameters, skin characteristics, and healing response.

The practitioner should confirm that the patient understands expected improvement, limitations, downtime, possible complications, and the possibility of multiple treatments. If expectations cannot be aligned, treatment should be deferred.

Additional Screening Issues That May Change the Plan

Ability to Follow Aftercare

A patient who cannot reliably follow wound-care instructions, sun protection requirements, or follow-up recommendations may face an avoidable risk of infection, delayed healing, scarring, or pigmentary alteration.

Some protocols classify inability to comply with postoperative care as an absolute contraindication, while others treat it as a reason to postpone or select a less aggressive approach. Regardless of terminology, treatment should not proceed without informed and realistic commitment to aftercare.

Scarring and Koebnerization History

A history of keloid or hypertrophic scarring, vitiligo, psoriasis, or other koebnerizing disorders may increase the risk of abnormal healing or new lesions after cutaneous injury.

These conditions are not included among the primary reference’s core absolute contraindications, but they warrant careful evaluation. Depending on the diagnosis, treatment area, and device, the practitioner may choose conservative settings, a test spot, specialist consultation, or avoidance.

Recent Sun Exposure or Resurfacing

Recent tanning, intense ultraviolet exposure, deep chemical peeling, dermabrasion, or prior radiation to the treatment area can increase the risk of burns, delayed healing, and post-inflammatory dyspigmentation.

The required postponement varies by procedure and protocol. The patient should be assessed for residual erythema, tanning, barrier disruption, and healing before treatment is scheduled.

Systemic and Medication-Related Risks

Diabetes, immunosuppression, heavy smoking, anticoagulant use, active inflammatory disease, and medications that affect photosensitivity or healing may require additional precautions. These factors are not automatically absolute contraindications in every fractional laser protocol.

They should prompt a medical history review, possible prescriber consultation, conservative parameters, enhanced infection precautions, or postponement. The more aggressive the ablation and the deeper the thermal injury, the more important these considerations become.

Understanding the Trade-offs

Do Not Treat All Contraindications as Equivalent

An active infection and a history of photosensitivity do not carry the same immediate decision pathway. The infection generally requires treatment deferral, whereas photosensitivity may require medication review, medical clearance, modified settings, or an alternative treatment.

Clear classification prevents both unsafe treatment and unnecessary exclusion of suitable patients.

Retinoid Timeframes Are Protocol-Dependent

The primary reference specifies a 6-month interval after isotretinoin or related oral retinoids. Supplementary protocols cite intervals ranging from 6 to 12 months, especially for ablative procedures.

This difference reflects variation in device type, treatment intensity, and institutional policy. Practitioners should document the retinoid name, dose, indication, and stop date, then apply the most conservative applicable device or medical protocol.

A Test Spot Is Not a Substitute for Screening

A small test area may help evaluate selected risks, such as pigmentary response, but it cannot make active infection, recent isotretinoin use, pregnancy-related uncertainty, or inability to follow aftercare safe.

Testing should supplement—not replace—medical history, examination, informed consent, and appropriate physician consultation.

How to Apply This to Your Screening Protocol

Use a documented checklist before every treatment and escalate uncertain cases rather than relying on assumptions.

If your primary focus is preventing serious adverse events: Exclude patients with active localized infection or isotretinoin or related oral retinoid use within the applicable washout period, beginning with the primary standard of 6 months.
If your primary focus is managing relative risk: Review photosensitivity, collagen vascular disease, light-sensitizing medications, pregnancy or breastfeeding, scarring history, recent procedures, and systemic healing risks.
If your primary focus is achieving predictable results: Confirm that expectations, treatment limitations, downtime, sun protection, and aftercare responsibilities are fully understood.
If your primary focus is protocol compliance: Verify the device manufacturer’s contraindications, retinoid interval, treatment-specific precautions, and requirements for physician consultation.

A rigorous screen separates patients who must wait from those who can proceed safely with appropriate precautions.

Summary Table:

Contraindication Type	Condition	Action
Absolute	Active localized infection	Postpone until resolved
Absolute	Recent/current oral isotretinoin (within 6 months)	Defer; follow device-specific washout
Relative	Photosensitivity	Review meds; consider modification
Relative	Pregnancy/Breastfeeding	Physician consultation; usually postpone
Relative	Unrealistic expectations	Educate; defer if not aligned

Ensure your practice meets the highest safety standards with BELIS's advanced fractional laser systems. Our devices are designed for clinics and premium salons, offering precision and reliability. Contact our experts today to learn how we can support your treatment protocols and elevate patient care. Contact us now